Guardant Health
GH
$16.07
Share price
-3.60%
Change (1 day)
-35.15%
Change (1 year)
Categories
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.
EPS for Guardant Health (GH)
EPS in 2023 (TTM): -$4.91
According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -$4.91. In 2022 the company made an earnings per share (EPS) of -$6.40 a decrease over its 2021 EPS that were of -$4.00.
EPS history for Guardant Health from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.91 | -23.28% |
| 2022 | -$6.40 | 60% |
| 2021 | -$4.00 | 55.04% |
| 2020 | -$2.58 | 207.14% |
| 2019 | -$0.84 | -19.81% |
| 2018 | -$1.05 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | -$0.12 | -97.57% | 🇺🇸 USA |
 Natera NTRA | -$4.82 | -1.83% | 🇺🇸 USA |